Education
About Us
Working with TipRanks
Follow Us
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
RESEARCH TOOLSreports
Comparison Results
Shanghai Henlius Biotech, Inc. Class H
HK$79.45
HK$43.18B
48.52
243.41%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$19.19
HK$25.14B
―
249.54%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$33.58
HK$48.71B
―
216.51%
1 Buy
0 Hold
1 Sell
Hold
Simcere Pharmaceutical Group Limited
HK$13.46
HK$34.94B
35.88
135.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascentage Pharma Group International
HK$77.55
HK$28.67B
―
137.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:2696
Shanghai Henlius Biotech, Inc. Class H
79.50
56.35
243.41%
DE:1ZLB
Zai Lab Ltd
2.54
0.78
44.32%
HK:9969
InnoCare Pharma Ltd.
19.19
13.42
232.58%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
33.74
23.08
216.51%
HK:2096
Simcere Pharmaceutical Group Limited
13.95
7.90
130.58%
HK:6855
Ascentage Pharma Group International
79.30
45.85
137.07%